Sasha Bernatsky1, Youssef Habel, Elham Rahme. 1. Division of Clinical Epidemiology, Department of Medicine, and the Research Institute, McGill University Health Centre, Montreal, Quebec, Canada. sasha.bernatsky@mail.mcgill.ca
Abstract
OBJECTIVE: Published metaanalyses of tumor necrosis factor (TNF) antagonists and infection have focused on randomized controlled trials, which tend to have short duration, relatively small size, and stringent inclusion/exclusion criteria that may limit enrollment to patients at low risk of infection. We performed a systematic review and synthesis of observational studies of TNF antagonists and infection risk. METHODS: We conducted a systematic literature search of studies estimating overall risk of serious infection after anti-TNF exposure in rheumatoid arthritis (RA). We estimated a pooled relative risk (RR) for the relevant observational studies, using a random-effects model. RESULTS: Five cohort studies and 2 nested case-control studies were included in the metaanalysis. Anti-TNF therapy appeared to significantly increase risk of serious infection (pooled adjusted RR 1.37, 95% CI 1.18, 1.60). CONCLUSION: Our metaanalysis of observational data demonstrated an increased risk of serious infection in subjects with RA receiving anti-TNF therapy, versus those not receiving these agents.
OBJECTIVE: Published metaanalyses of tumor necrosis factor (TNF) antagonists and infection have focused on randomized controlled trials, which tend to have short duration, relatively small size, and stringent inclusion/exclusion criteria that may limit enrollment to patients at low risk of infection. We performed a systematic review and synthesis of observational studies of TNF antagonists and infection risk. METHODS: We conducted a systematic literature search of studies estimating overall risk of serious infection after anti-TNF exposure in rheumatoid arthritis (RA). We estimated a pooled relative risk (RR) for the relevant observational studies, using a random-effects model. RESULTS: Five cohort studies and 2 nested case-control studies were included in the metaanalysis. Anti-TNF therapy appeared to significantly increase risk of serious infection (pooled adjusted RR 1.37, 95% CI 1.18, 1.60). CONCLUSION: Our metaanalysis of observational data demonstrated an increased risk of serious infection in subjects with RA receiving anti-TNF therapy, versus those not receiving these agents.
Authors: Benjamin Voss; Alexander Kurdi; Alexander Skopec; Jasmine Saleh; Mouhanad M El-Othmani; Joseph M Lane; William M Mihalko; Khaled J Saleh Journal: J Nat Sci Date: 2015-02-01
Authors: Jasvinder A Singh; Chris Cameron; Shahrzad Noorbaloochi; Tyler Cullis; Matthew Tucker; Robin Christensen; Elizabeth Tanjong Ghogomu; Doug Coyle; Tammy Clifford; Peter Tugwell; George A Wells Journal: Lancet Date: 2015-05-11 Impact factor: 79.321
Authors: Carlos G Grijalva; Lang Chen; Elizabeth Delzell; John W Baddley; Timothy Beukelman; Kevin L Winthrop; Marie R Griffin; Lisa J Herrinton; Liyan Liu; Rita Ouellet-Hellstrom; Nivedita M Patkar; Daniel H Solomon; James D Lewis; Fenglong Xie; Kenneth G Saag; Jeffrey R Curtis Journal: JAMA Date: 2011-11-06 Impact factor: 56.272
Authors: Najia Hajjaj-Hassouni; Marzooq Al-Badi; Ala' Al-Heresh; Samar Al-Emadi; Ahmed El Bawendi; Ayman El Garf; Khaled El Hadidi; Hussein Halabi; Mohammed Hammoudeh; Selma El Hassani; Mustafa Al Maaini; Ibrahim Nahar; Aïcha Ladjouze Rezig; Slaheddine Sellami; Wafaa Sweiri; Ramiz Alswailem; Beverly Traub; Imad Uthman; Elsa van Duuren; Leith Zakraoui; Bassel El Zorkany; Loreto Carmona; Maxime Dougados Journal: Clin Rheumatol Date: 2012-01-07 Impact factor: 2.980
Authors: Shannon M Lange; Melanie C McKell; Stephanie M Schmidt; Austin P Hossfeld; Vandana Chaturvedi; Jeremy M Kinder; Jaclyn W McAlees; Ian P Lewkowich; Sing Sing Way; Joanne Turner; Joseph E Qualls Journal: Front Immunol Date: 2017-11-16 Impact factor: 7.561